Medical Devices Startups

Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample. It provides custom assay development and bioanalytical services to researchers for biomarker discovery, disease-signature analysis, and translational research in oncology, neurology, and other disease areas.

1 investor

Adialante develops mobile MRI imaging units that arrive at clinical practices for diagnostic scanning, eliminating the need for hospital-based imaging facilities. The company serves private practices and clinics seeking to offer diagnostic-grade MRI services without capital investment or facility construction.

1 investor

Adiuvo Diagnostics develops imaging technology powered by machine learning for disease detection in low-resource settings. The company's platform captures multispectral autofluorescence images to enable fast, label-free diagnostics across pathogen detection, skin health, and cancer diagnosis.

1 investor

Adler Ortho designs, manufactures, and markets joint prostheses and medical devices for the orthopaedic market. The company operates manufacturing facilities across Italy and serves customers globally through distribution partners.

1 investor

Advanced Bifurcation Systems develops the ABS Platform, a dual-catheter stent delivery system for treating coronary bifurcation lesions with guaranteed side branch access. The device targets interventional cardiologists performing provisional stenting of bifurcations.

1 investor

Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.

1 investor

Advanced Bionics manufactures cochlear implant technology and sound processors for adults and children with severe hearing loss, including devices that connect to a telehealth app and integrate with Phonak hearing aids for bimodal solutions. It is a global hearing-technology company operating as a Sonova brand and sister company to Phonak.

1 investor

Advanced Diagnostic Group provides radiology and medical diagnostic imaging services including MRI, X-ray, and CT scans for patients. The company operates imaging facilities equipped with modern equipment and prioritizes fast turnaround of results to physicians.

1 investor

Advanced Medical Balloons develops and manufactures high-tech balloon systems for treating fecal incontinence in critical care settings, headquartered in Germany.

1 investor

Advanced Silicon Group works in nanotechnology, using the tagline "Nanotechnology for Life."

1 investor

Advantage Surgical and Wound Care provides wound healing and surgical condition treatment to patients in post-acute care settings, using evidence-based conservative approaches and telemedicine to reduce unnecessary hospitalizations and emergency room visits.

1 investor

Advantageous Systems combines nanotechnology, material science, and biotechnology to develop smart materials for medical devices, therapeutics, and clean technology applications. The company has commercialized nanotechnology solutions, particularly in water treatment.

1 investor

Advantis Medical Imaging develops cloud-based software to make advanced medical imaging more accessible and user-friendly for healthcare professionals. The company combines medical imaging technology with cloud infrastructure to improve data-driven diagnostic workflows.

1 investor

ADVENT is an ENT medical practice that treats upper airway conditions including nasal blockage, sinus infections, snoring, and sleep apnea through team-based care and office-based procedures. With 35 locations across six states, the practice serves over 1,500 new patients monthly using innovative approaches including in-office CT scans and at-home sleep studies.

1 investor

Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).

1 investor

Advosense develops disposable smart sensor stickers that monitor patient dryness and send real-time notifications to clinicians when incontinence care is needed. The product is aimed at clinicians providing geriatric and elderly care and integrates into existing care workflows.

1 investor

Aegis operates a clinical laboratory providing definitive drug and substance testing services for healthcare providers, pharmaceutical companies, sports organizations, and corporations. The company offers medication monitoring, drug screening, and laboratory analytics integrated with electronic medical records systems.

1 investor

AEON Biopharma develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for patients with neuromuscular disorders. The company focuses on expanding access to high-quality neurotoxin therapies through proprietary drug development.

1 investor

Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer. The company is conducting clinical testing to validate the panel's ability to detect lung cancer, distinguish its stages and aggressiveness, and identify other lung conditions.

1 investor

A medical device company developing orthopedic and biological solutions. Leadership includes experienced physicians, financial executives, and medical technology sales professionals.

1 investor

Aerogen develops aerosol drug delivery systems for hospital and ICU use, enabling targeted delivery of proteins, peptides, and solutions to the lungs. The company is a global leader in ventilator-based aerosol drug delivery for critical care settings.

1 investor

AesculaTech develops smart materials that change properties in response to temperature and other stimuli, applying this platform to biomedical, industrial, and cosmetic products. Its first product, Humidifeye, is a smart-gel punctal plug for dry eye treatment, alongside research into patient-adaptable medical hydrogels, high-strength films, and composites.

1 investor

Aesyra develops and manufactures a medical device to monitor and treat Sleep Bruxism. Founded as a spin-off of EPFL, the company targets patients affected by sleep bruxism worldwide and is based in Switzerland.

1 investor

aetherAI develops medical technology using artificial intelligence for the healthcare sector, presenting investment opportunities to prospective backers.

1 investor